Zimmermann Martine
- SEC CIK
- 0001994049
In the past year, 1 open-market sale filing worth $342.0K and no purchases.
Current role at each company
- LGND Ligand Pharmaceuticals IncDirectoras of Sep 24, 2026
- CADL Candel Therapeutics, Inc.Directoras of Sep 10, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $342.0K
- 1 filing
- Net
- −$342.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Zimmermann Martine as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LGND Ligand Pharmaceuticals Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 (view filing)4:59 PM ET | Sep 10 | 4 days | Zimmermann MartineDirector | SSale | −1.20K | $285.00 | −$342.0K | −23.5%3.90K after |